Literature DB >> 1330572

Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects.

V Schuster1, H W Kreth.   

Abstract

Epstein-Barr virus (EBV), an ubiquitous human B lymphotropic virus, is the cause of infectious mononucleosis. Moreover, EBV infection can be followed by lymphoproliferative diseases in patients with inherited and acquired immunodeficiencies. Primary EBV infection may be a threat to all children after marrow or organ transplantation or those receiving chronic immunosuppressive treatment for various other reasons. The virus has been also implicated in the pathogenesis of different malignant tumours such as Burkitt lymphoma, nasopharyngeal carcinoma, Hodgkin disease and some T-cell lymphomas. This review focuses on various aspects of virus-host interactions, immune mechanisms of the host, and the still experimental therapeutic approaches in EBV-associated diseases.

Entities:  

Mesh:

Year:  1992        PMID: 1330572     DOI: 10.1007/bf01959075

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  111 in total

1.  Chromosome translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes.

Authors:  T Aya; T Kinoshita; S Imai; S Koizumi; F Mizuno; T Osato; C Satoh; T Oikawa; N Kuzumaki; H Ohigashi
Journal:  Lancet       Date:  1991-05-18       Impact factor: 79.321

2.  Burkitt lymphoma in a child with human immunodeficiency virus infection.

Authors:  N Kamani; J Kennedy; J Brandsma
Journal:  J Pediatr       Date:  1988-02       Impact factor: 4.406

3.  Prevalence, incidence and persistence of EB virus antibody in young adults.

Authors:  J C Niederman; A S Evans; L Subrahmanyan; R W McCollum
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

Review 4.  The changing faces of EBV research.

Authors:  G Klein; E Klein
Journal:  Prog Med Virol       Date:  1984

Review 5.  Role of epithelium in EBV persistence and pathogenesis of B-cell tumours.

Authors:  M J Allday; D H Crawford
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321

6.  Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.

Authors:  D W Hanto; G Frizzera; K J Gajl-Peczalska; K Sakamoto; D T Purtilo; H H Balfour; R L Simmons; J S Najarian
Journal:  N Engl J Med       Date:  1982-04-15       Impact factor: 91.245

7.  Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.

Authors:  B E Tomkinson; R Maziarz; J L Sullivan
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

8.  Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.

Authors:  W Hammerschmidt; B Sugden
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

9.  Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

Authors:  M Ho; G Miller; R W Atchison; M K Breinig; J S Dummer; W Andiman; T E Starzl; R Eastman; B P Griffith; R L Hardesty
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

10.  Persistent Epstein-Barr virus infection and pregnancy.

Authors:  G Fleisher; R Bolognese
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

View more
  5 in total

1.  Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland.

Authors:  N S Crowcroft; A Vyse; D W Brown; D P Strachan
Journal:  J Epidemiol Community Health       Date:  1998-02       Impact factor: 3.710

2.  Epstein-Barr virus associated lymphoproliferative disorder with fatal involvement of the gastrointestinal tract in an infant.

Authors:  L X Pan; P Ramani; T C Diss; L N Liang; P G Isaacson
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

Review 3.  Posttransplant lymphoproliferative disease after pediatric solid organ transplantation.

Authors:  Martin Mynarek; Tilmann Schober; Uta Behrends; Britta Maecker-Kolhoff
Journal:  Clin Dev Immunol       Date:  2013-09-24

4.  Andrographolide Inhibits Epstein-Barr Virus Lytic Reactivation in EBV-Positive Cancer Cell Lines through the Modulation of Epigenetic-Related Proteins.

Authors:  Praphatson Malat; Tipaya Ekalaksananan; Chukkris Heawchaiyaphum; Supawadee Suebsasana; Sittiruk Roytrakul; Yodying Yingchutrakul; Chamsai Pientong
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

Review 5.  The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.

Authors:  Mei-Fong Pang; Kah-Wai Lin; Suat-Cheng Peh
Journal:  Cell Mol Biol Lett       Date:  2008-12-13       Impact factor: 5.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.